Musculoskeletal manifestations in cystic fibrosis

被引:59
作者
Botton, E
Saraux, A [1 ]
Laselve, H
Jousse, S
Le Goff, P
机构
[1] CHU Brest, Hop Cavale Blanche, Serv Rhumatol, F-29609 Brest, France
[2] Ctr Helio Marin, Roscoff, France
关键词
cystic fibrosis; demineralization; arthralgia; arthritis; immunological manifestations;
D O I
10.1016/S1297-319X(03)00063-0
中图分类号
R5 [内科学];
学科分类号
1002 [临床医学]; 100201 [内科学];
摘要
Although bone and joint manifestations are common in children with cystic fibrosis (CF), they have received little attention in adults. As compared to healthy individuals, bone mineral density is low, even with calcium intakes greater than 1500 mg/d. Nevertheless, calcium and phosphate levels in blood and urine are often normal, and vitamin D levels vary. Short stature with a low body mass index and central hypogonadism are the rule in these patients. Fractures and kyphosis are often reported. CF arthropathy occurs in 2-8.5% of patients. Arthritis develops, and there may be skin eruptions. Non-steroidal anti inflammatory drug therapy is effective. Hypertrophic osteoarthropathy associated with respiratory failure is present in 2-7% of patients. Rheumatoid arthritis, spondyloarthropathies, sarcoidosis, and amyloidosis have been reported in association with CF. Knee pain due to patellofemoral syndrome, quinolone-induced arthropathy, and mechanical back pain have been described. Rheumatoid factor titers are higher than in healthy controls, particularly in patients with episodic arthritis. No data are available on antiperinuclear factor or antikeratin antibody titers. Tests for antinuclear antibody are usually negative. Circulating immune complex levels and antibodies to heat shock proteins may be elevated. Antineutrophil cytoplasmic antibody of the bactericidal/permeability-increasing protein (BPI) or azurocidin (AZ) type has been reported, often in high titers (up to 40%). (C) 2003 Editions scientifiques et medicales Elsevier SAS. All rights reserved.
引用
收藏
页码:327 / 335
页数:9
相关论文
共 134 条
[1]
Role of heat shock proteins in the pathogenesis of cystic fibrosis arthritis [J].
AlShamma, MRR ;
McSharry, C ;
McLeod, K ;
McCruden, EAB ;
Stack, BHR .
THORAX, 1997, 52 (12) :1056-1059
[2]
Efficacy of pamidronate for osteoporosis in patients with cystic fibrosis following lung transplantation [J].
Aris, RM ;
Lester, GE ;
Renner, JB ;
Winders, A ;
Blackwood, AD ;
Lark, RK ;
Ontjes, DA .
AMERICAN JOURNAL OF RESPIRATORY AND CRITICAL CARE MEDICINE, 2000, 162 (03) :941-946
[3]
Severe osteoporosis before and after lung transplantation [J].
Aris, RM ;
Neuringer, IP ;
Weiner, MA ;
Egan, TM ;
Ontjes, D .
CHEST, 1996, 109 (05) :1176-1183
[4]
Increased rate of fractures and severe kyphosis: Sequelae of living into adulthood with cystic fibrosis [J].
Aris, RM ;
Renner, JB ;
Winders, AD ;
Buell, HE ;
Riggs, DB ;
Lester, GE ;
Ontjes, DA .
ANNALS OF INTERNAL MEDICINE, 1998, 128 (03) :186-193
[5]
CYSTIC-FIBROSIS AND HYPERTROPHIC OSTEOARTHROPATHY IN CHILDREN - REPORT OF 3 CASES [J].
ATHREYA, BH ;
BORNS, P ;
ROSENLUND, ML .
AMERICAN JOURNAL OF DISEASES OF CHILDREN, 1975, 129 (05) :634-637
[6]
OSTEOPENIA IN ADULTS WITH CYSTIC-FIBROSIS [J].
BACHRACH, LK ;
LOUTIT, CW ;
MOSS, RB ;
MARCUS, R .
AMERICAN JOURNAL OF MEDICINE, 1994, 96 (01) :27-34
[7]
Bone demineralization in cystic fibrosis: Evidence of imbalance between bone formation and degradation [J].
Baroncelli, GI ;
DeLuca, F ;
Magazzu, G ;
Arrigo, T ;
Sferlazzas, C ;
Catena, C ;
Bertelloni, S ;
Saggese, G .
PEDIATRIC RESEARCH, 1997, 41 (03) :397-403
[8]
BENJAMIN CM, 1990, BRIT J RHEUMATOL, V29, P301
[9]
BERNISCHEWSKY M, 1980, PEDIATR RES, V14, P830
[10]
Bhudhikanok GS, 1996, PEDIATRICS, V97, P103